Venrock Healthcare Capital Partners III, L.P., 10% Owner at Unum Therapeutics Inc. (UMRX), bought 551,000 shares at $2.57 ($1.4M) on 2020-08-17, disclosed to the SEC on 2020-08-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.30 | 100,000 | $230K | 16.8% |
| 2 | $2.30 | 100,000 | $230K | 16.8% |
| 3 | $2.57 | 250,000 | $643K | 47.0% |
| 4 | $2.62 | 101,000 | $265K | 19.4% |
| Total | $2.48 avg | 551,000 | $1.4M | 100% |
| Filing → |
| KALV | BUY | 2024-02-01 | $2.5M | — | Filing → |
| KALV | BUY | 2024-01-29 | $1.4M | — | Filing → |
| KALV | BUY | 2024-01-10 | $2.8M | — | Filing → |